Group 1 - The stock price of Walden Materials (09981) rose by over 7% in early trading, currently up 3.50% at HKD 20.72, with a trading volume of HKD 304 million [1][4] - At the GTC 2026 conference on March 16, NVIDIA's CEO Jensen Huang introduced the world's first mass-produced Co-Packaged Optics (CPO) switch, Spectrum X, addressing market concerns regarding the transition from copper to optical technology [1][4] - Huatai Securities previously indicated a positive outlook for Walden Materials' high-speed communication cable business, anticipating growth driven by domestic and international AI short-distance interconnect demand [1]

展望2026年，该行预期在iPhone Fold、新能源车产品渗透及人工智能服务器订单的带动下，收入增长将 更为强劲，部分被存储器成本上升导致的Android需求疲弱所抵销。该行下调2025至2027年每股盈利预 测1%至13%，以计入2026年智能手机及汽车行业的不利因素。该行对比亚迪电子在2026至2027年新能 源车产品量产及人工智能服务器产品的业务前景仍持正面看法。该行将其目标价从43.54港元下调至 39.69港元，维持"买入"评级。 招银国际发表研报指，估计比亚迪电子2025下半年收入及纯利分别为963亿元及25.3亿元，意味着第四 季收入及纯利分别按年减少3%及减少7%，主要由于智能手机及汽车行业的不利因素，尽管毛利率按年 有所改善。 ...

Core Viewpoint - The innovation drug sector in China is experiencing significant growth, driven by new drug approvals and favorable policy changes, with a focus on the performance of the ChiNext Innovation Drug ETF. Group 1: Market Performance - The ChiNext Innovation Drug Index rose by 3.42% as of March 17, 2026, with notable increases in constituent stocks such as Sangfor Biopharma (up 9.72%) and Yuandong Biotech (up 7.96%) [1] - The ChiNext Innovation Drug ETF (Huitianfu) increased by 3.23%, reaching a latest price of 0.8 yuan, and has seen a cumulative increase of 1.84% over the past week [1] - The ETF recorded a turnover rate of 3.90% with a trading volume of 19.21 million yuan, and an average daily trading volume of 33.78 million yuan over the past year [1] Group 2: Fund Growth and Inflows - The ChiNext Innovation Drug ETF saw a significant scale increase of 10.69 million yuan over the past two weeks, ranking in the top half among comparable funds [3] - The ETF's share count grew by 39 million shares in the past month, also placing it in the top half of comparable funds [3] - Despite a recent net outflow of 2.30 million yuan, the ETF experienced net inflows on 10 out of the last 15 trading days, totaling 30.51 million yuan [3] Group 3: Company Developments - Rongchang Biopharma's RC288 injection has received acceptance from the NMPA, showcasing promising anti-tumor activity and safety in preclinical studies [3] - Rongchang Biopharma is expected to enter a new growth phase starting in 2026, benefiting from new indications for RC18, RC48, and RC28, along with international sales starting in 2027 [4] - The company anticipates revenue from multiple asset authorizations beginning in 2025, which will enhance its financial statements [4] Group 4: Industry Trends - The new National Basic Medical Insurance Drug List has added 114 new drugs, including 50 innovative drugs, with a negotiation success rate of 88%, indicating a robust market for innovative drugs [5] - The commercialization of innovative drugs is accelerating, supported by improved payment systems and a green channel for insurance access [5] - The CXO industry is highlighted as a strong investment opportunity, with ongoing improvements in global pharmaceutical R&D and increasing collaboration between Chinese companies and multinational corporations [6]

Core Viewpoint - The announcement indicates that the company has been selected by GAC Group to develop and supply power batteries, marking a significant recognition of its SPS battery products in the market [2] Group 1: Partnership and Product Development - The company's wholly-owned subsidiary, Guangzhou Funeng Technology Co., Ltd., has received a "Designation Development Notice" from GAC Group [2] - GAC Group forecasts that the company will begin supplying batteries in the first half of 2027 [2] - The project will utilize the SPS (Super Punch Solution) design for lithium iron phosphate power batteries, indicating a breakthrough in the new energy passenger vehicle sector [2] Group 2: Financial Performance and Production Capacity - The company has issued a profit forecast for 2025, expecting a net loss attributable to shareholders of between -830 million yuan and -580 million yuan [2] - The net profit, excluding non-recurring gains and losses, is projected to be between -861.8 million yuan and -611.8 million yuan [2] - The company’s two new production bases are still in the ramp-up phase, facing high fixed depreciation costs, and are working on improving capacity utilization, equipment efficiency, and yield rates [2]

Core Insights - Hesai Technology has joined the NVIDIA Halos AI system detection lab, the first globally recognized project certified by the American National Standards Institute National Accreditation Board (ANAB) [1][3] - The NVIDIA Halos system is a comprehensive safety framework for physical AI, aimed at ensuring the safe development of autonomous vehicles and robotics [1][3] Group 1: Company Developments - Hesai's CEO, Li Yifan, emphasized that safety and reliability are paramount for the widespread application of autonomous systems, especially as they move towards large-scale deployment [3] - The company has delivered over 2 million LiDAR units globally, which are used in advanced driver-assistance systems (ADAS), autonomous vehicles, and robotics [3][4] - Hesai has established a "three-in-one" safety system that integrates functional safety, expected functional safety, and cybersecurity into its LiDAR system design [4] Group 2: Industry Collaboration - The partnership with NVIDIA builds on a long-term collaboration that began in 2019, reinforcing Hesai's position as a key ecosystem partner [4] - Hesai has been selected as a LiDAR partner for NVIDIA's "DRIVE AGX Hyperion 10" platform, which aims to help various vehicle models achieve Level 4 autonomous driving capabilities [4] - The collaboration is part of a broader industry effort to create a credible safety system as autonomous technology transitions from research to large-scale deployment [5]

二是利润端缩减。为应对销量下滑，公司加大促销力度，自主品牌单车平均促销投入占比较上年上升5 个百分点，但未能实现销量回升。 3月15日晚，广汽集团（601238）发布关于上交所对公司业绩预告相关事项监管工作函的回复公告称， 公司2025年度毛利率为负的主要原因为：一是收入端下降。公司自主品牌乘用车销量同比下滑 22.83%，叠加终端促销费用的增加，造成整车制造业收入规模收缩。 三是成本端抬升。产能利用率不足推高单位固定成本，单辆人工成本、折旧摊销及其他固定成本较上年 同比增加超40%，叠加上游原材料价格高位运行的潜在压力，最终推动单车成本上升。 ...

国家知识产权局信息显示，中国建设银行股份有限公司取得一项名为"目标对象识别方法、装置、设备 及存储介质"的专利，授权公告号CN115471722B，申请日期为2022年9月。 天眼查资料显示，中国建设银行股份有限公司，成立于2004年，位于北京市，是一家以从事货币金融服 务为主的企业。企业注册资本26160038.1459万人民币。通过天眼查大数据分析，中国建设银行股份有 限公司共对外投资了37家企业，参与招投标项目44975次，财产线索方面有商标信息1895条，专利信息 5000条，此外企业还拥有行政许可149个。 建信金融科技有限责任公司，成立于2018年，位于上海市，是一家以从事软件和信息技术服务业为主的 企业。企业注册资本172972.9729万人民币。通过天眼查大数据分析，建信金融科技有限责任公司共对 外投资了6家企业，参与招投标项目4484次，财产线索方面有商标信息294条，专利信息5000条，此外企 业还拥有行政许可10个。 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 ...

Group 1 - The core point of the article is that the Industrial and Commercial Bank of China (ICBC) has obtained a patent for a method and device related to a target model pruning method, with the patent granted under announcement number CN116227555B and the application date being March 2023 [1] - ICBC was established in 1985 and is headquartered in Beijing, primarily engaged in monetary financial services [1] - The registered capital of ICBC is approximately 35.64 billion RMB [1] Group 2 - According to data analysis from Tianyancha, ICBC has made investments in 28 companies and participated in 10,980 bidding projects [1] - The bank holds 969 trademark registrations and has 5,000 patent records [1] - Additionally, ICBC possesses 79 administrative licenses [1]

Core Viewpoint - Nvidia plans to invest a total of $26 billion over the next five years to advance the development of open-source AI large models, marking a strategic shift from being a "chip manufacturer" to a "full-stack AI top laboratory" [1] Investment Recommendations Computing Power - Recommended companies include Nvidia (NVDA.O), TSMC (TSM.N), ASML (ASML.O), and Broadcom (AVGO.O) [1] Cloud Providers - Recommended North American cloud providers are Microsoft (MSFT.O), Amazon (AMZN.O), and Google (GOOGL.O) [1] AI Applications - Companies benefiting from AI Agent direction include Apple (AAPL.O), Qualcomm (QCOM.O), Lenovo Group (0992.HK), and Xiaomi Group (1810.HK). Tesla (TSLA.O) is highlighted for its benefits in the Physical AI direction [1] AI Social - Recommended social network giants empowered by AI include Tencent Holdings (0700.HK), Meta (META.O), and Google (GOOGL.O) [1]

Core Viewpoint - BYD's second-generation fast charging technology claims to charge an electric vehicle in 5 minutes for a partial charge and 9 minutes for a full charge, even in low temperatures, marking a significant advancement in charging efficiency [2] Group 1: Technology Performance - The second-generation fast charging technology was tested in Beijing on February 10, showcasing its performance in winter conditions with temperatures around zero degrees [2] - Eight BYD models participated in the test, with starting battery levels around 20%, charging to 97% capacity [2] - The fastest charging time recorded was 9 minutes and 42 seconds for the Song Ultra model, while the longest was 10 minutes and 22 seconds for the Tengshi N9 model [2][6] Group 2: Industry Impact - The second-generation fast charging technology addresses the common issue of long charging times for electric vehicles, especially in winter when charging efficiency typically decreases [2] - This technology significantly reduces charging anxiety for electric vehicle owners, bringing charging times closer to traditional fuel refueling times [7] - The advancement is expected to promote the growth of the electric vehicle industry, particularly increasing market penetration in northern regions [7]